Prescribers can now consult a quick-reference MIMS table for a summary of monitoring requirements for ACE inhibitors and angiotensin II antagonists.
Covering use of Athe antihypertensives in patients with heart failure, hypertension, chronic kidney disease and following MI, the table summarises the tests needed when starting the drugs, until treatment is stabilised, and subsequently.
Circumstances in which treatment should be stopped are also noted.
Recommendations in the table are summarised from NICE guidelines, CKS and SIGN.
The table is available online and will appear in the forthcoming September quarterly print issue of MIMS.